Yaz, Yasmin Settlements Reached in More than 17,000 Cases: Bayer
About two years after Bayer began settling Yaz and Yasmin lawsuits, the drug maker indicates that it has now reached agreements to resolve more than 17,000 cases brought by women who allege they suffered blood clots and other injuries after using the popular birth control pills. However, the drug maker continues to face thousands of lawsuits involving the drugs, which may ultimately require trial dates throughout the country.
According to disclosures made in Bayer’s 2013 annual report, the drug maker has already agreed to pay about $1.69 billion to settle about 8,250 cases involving allegations that women suffered venous clot injuries, including a pulmonary embolism or deep vein thrombosis. In addition, Bayer has agreed to pay a total of $24 million to resolve another 8,800 complaints brought by women who allege they suffered a gallbladder injury from Yaz or Yasmin.
As of February 10, Bayer indicates that about 4,600 Yaz lawsuits, Yasmin lawsuits, Ocella lawsuits and Gianvi lawsuits continue to be unresolved. In addition, at least 13 Yaz class action lawsuits have been served on the drug maker in Canada, with another in Israel.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Bayer is continuing to negotiate Yaz settlements on a case-by-case basis for claims involving a venous clot injury following a review of medical records and negotiations with lawyers across the country. The drug maker estimates that about 1,950 of the remaining lawsuits involve claims that the drug maker is considering settling.
That will leave more than 2,500 complaints unresolved, and the drug maker indicates that additional lawsuits are expected. Bayer stated in the annual report that it “believes that it has meritorious defenses and will continue to defend itself vigorously against all claims that are not considered for settlement.”
Yaz and Yasmin Litigation
Yaz and Yasmin are popular birth control pills that contain the fourth-generation progestin drospirenone, which has been associated with an increased risk of blood clots compared to the risk associated with some older birth control pills. Gianvi and Ocella are generic versions of the drugs, which were manufactured by Bayer and distributed by other drug makers.
All of the complaints involve similar allegations that Bayer failed to provide adequate warnings for women about the increased risk of injury associated with side effects of Yasmin and Yaz.
Women allege that they may have avoided serious and debilitating injuries if adequate warnings had been provided about the risk of deep vein thrombosis, pulmonary embolism, gallbladder disease, heart attacks, and strokes. While all birth control pills carry an increased risk of blood clots, public attention turned to the problem after a number of deaths involving young, healthy women.
In the federal court system, the Yaz and Yasmin litigation has been consolidated as part of an MDL in the Southern District of Illinois, which grew at one point to become the largest consolidated litigation in the United States, with the total number of active cases surpassing the asbestos litigation last year.
If agreements are not reached to settle all cases, it is possible that lawsuits pending in the federal court system will be remanded back to the U.S. District Courts where they were originally filed for individual trial dates. However, the litigation has been essentially stayed since January 2012, when the first trial dates in the federal MDL were cancelled amid the start of settlement negotiations.
ECNMarch 10, 2014 at 2:47 pm
How is it that the science doesn't back up the gallbladder cases? My attorney has let me know that my gallbladder case will only receive $3000 for my gallbladder failure, hypertension, the need to be near a bathroom for the rest of my life, migraines that have not gone away, heavy bleeding, bloating etc. damages caused by my birthcontrol pill (YAZ) almost as soon as I started taking them...And the[Show More]How is it that the science doesn't back up the gallbladder cases? My attorney has let me know that my gallbladder case will only receive $3000 for my gallbladder failure, hypertension, the need to be near a bathroom for the rest of my life, migraines that have not gone away, heavy bleeding, bloating etc. damages caused by my birthcontrol pill (YAZ) almost as soon as I started taking them...And they let me know that after all is said and done and they get paid maybe not even that???? I am very confused...They stated that Bayer will not admit to a fault because their product doesn't give gallbladder damage...but FDA regulations have posted that the label must include whatever women have reported to have suffered from when using this product and gallbladder disease is in the warning labels now??? I am extremely confused...and my life is not even worth $3000??? Where is the justice...those who suffered from other illnesses are rewarded for their pain and suffering over $200,000....and the warning label has those illnesses posted as well as the gallbladder disease on them, but gallbladder illnesses and other associated with the use of YAZ aren't worth a damn?! I regret the day the doctor prescribed me YAZ...The most heartbreaking thing I have ever had to suffer...Three weeks of recover from the gallbladder surgery, job income loss, having to go to the bathroom more often, being close to a bathroom at all times, ongoing migraines, never ending cramps, hypertensive...I'm glad my life is meaningless and worthless and my suffering the same...
"*" indicates required fields
More Top Stories
A Camp Lejeune non-Hodgkin's lymphoma lawsuit blames the death of a woman on her exposure to contaminated water from the military base.
Defendants want to divide the discovery process to focus on the causal links between hair relaxers and cancer.
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.